Thursday, 14 November 2019

Vaccines News

  • NIH develops groundbreaking dengue vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jan, 2013

    Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has generated a strong immune response. The early-stage clinical trial wa...Read more

  • GSK's malaria vaccine might be reality in two years

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The results of the phase III clinical trials of a malaria vaccine being developed by British pharmaceutical major GlaxoSmithKline has managed to bring some good news for the cont...Read more

  • Sanofi working to bring dengue under control

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press conference held by the company recently. The extensive clinical study proved...Read more

  • CSL Biotherapies awarded Pandemic Preparedness Contract by US Government

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to t...Read more

  • Serum Institute acquires Dutch biologics company

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

    Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine company, has acquired Bilthoven Biologicals of Netherlands. Through the...Read more

  • Mitsubishi to acquire Medicago at $1.16 per share

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VL...Read more

  • H7N9 claims more lives in China

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2014

    Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new human cases of H7N9 Avian Influenza in four Chinese provinces. The de...Read more

  • Vaccines do not cause autism: Study

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

    Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childhood vaccination programs. In a study that covered more than 1.25 milli...Read more

  • EU join hands to develop personalized cancer vaccines

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to create, manufacture and develop actively personalized vaccines (APVACs) to...Read more

  • Focus on needs of society: Dr Weidong Yin

    Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

    Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of the Year Award for 2011. Sinovac was established in 2001 with a missio...Read more

  • Panacea gets govt order worth $34 million

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million dos...Read more

  • Emergent to market VaxInnate flu vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

    Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusive right to manufacture and sell VaxInnate's pandemic influenza vacci...Read more

  • WHO: Bird flu is back in China

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family Planning Commission to World Health Organization (WHO). The cases we...Read more

  • FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-culture-derived vaccine, for individuals 18 years of age and older. Develo...Read more

  • Takeda acquires LigoCyte Pharmaceuticals at $60 mn

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

  • FDA approves GSK's combo meingitis vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Men...Read more

  • Biodiem gets US patent allowance for antifungal therapy

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

  • Arterial Remodeling Technologies receives regulatory approval

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

      Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccin...Read more